• Loading...
    Contact Us

    Birth Defects Epidemiology & Surveillance
    Mail Code 1964
    P.O. Box 149347
    Austin, TX 78714-9347

    Phone: 512-776-7232
    Fax: 512-776-7330


    Email comments or questions

BIRTH DEFECT RISK FACTOR SERIES: ANAL ATRESIA-STENOSIS

Loading...

Click here for an Adobe PDF version of this document. (180KB PDF, Viewing Information)

NEW: Please take a moment to evaluate our birth defects risk factor series. Click here to take survey.

DEFINITION

Anal atresia/stenosis is the absence, closure, or constriction of the rectum or anus. It includes the diagnosis of imperforate anus. This condition is one of the more common defects of the gastrointestinal tract (Forrester 2002). Anal atresia/stenosis is usually diagnosed shortly after delivery.

While anal atresia/stenosis can occur as an isolated defect, it is often associated with other birth defects (Forrester 2002, Garne 2002, Haeusler 2002, Stoll 1996, Harris 1995, Castilla1990). Anal atresia/stenosis is often associated with a group of defects called the VACTERL syndrome; this syndrome causes vertebral, anal, cardiac, trachea, esophageal, renal, and limb abnormalities (Moore 1998). This defect can also be associated with chromosomal abnormalities, particularly trisomy 21 (Haeusler 2002, Bianco 2000, Torfs 1998, Stoll 1997, Kallen 1996, Harris 1995).

DEMOGRAPHIC AND REPRODUCTIVE FACTORS

While some studies failed to find a significant association between race/ethnicity and anal atresia/stenosis (Stoll 1997, Yang 1994), several studies have reported the anal atresia/stenosis rate to be slightly lower in African-Americans (Harris 1995, Chavez 1988), and another reported the rate of rectal/anal atresia to be higher in Europeans and South Asians than in Caribbeans (Leck 1995). A New York study found atresia/stenosis of the anus or rectum to be significantly lower among Mexican-born Hispanic women when compared with Hispanic mothers born in the U.S., Cuba, or Central/South America (Zhu 2006).

More than one investigation found no secular trend for anal atresia/stenosis (Forrester 2002, Spouge 1986), while another investigation reported an increase in the rate of the defects over time (Yang 1994). Anal atresia/stenosis does not appear to demonstrate seasonal variation (Stoll 1997, Castilla 1990).

Geographic location does not affect risk for anal atresia/stenosis (Stoll et al., 1997), except that one investigation identified an increased risk of the defects with higher altitude (Castilla 1999).

The association between anal atresia/stenosis and maternal age has been reported to be U-shaped (Harris 1995, Yang 1994) or to increase with increasing maternal age (Myers 2001), although another study found no association between maternal age and the condition (Stoll 1997). However, one confounding factor is that advanced maternal age is associated with an increase in chromosomal abnormalities (which often produce multiple defects); there is limited data available for non-chromosomal or isolated anal atresia/stenosis (Forrester 2002, Cuschieri 2001). Paternal age does not appear to influence anal atresia/stenosis risk (Stoll 1997, McIntosh 1995).

Infant sex may influence anal atresia/stenosis risk, with the condition being more common among males (Lisi 2005, Haeusler 2002, Lary 2001, Myers 2001, Cuschieri 2001, Riley 1998, Harris 1995, Spouge 1986), although several studies found no relationship between sex and anal atresia/stenosis (Stoll 1997, Yang 1994).

Anal atresia/stenosis risk increases with lower birth weight (Riley 1998, Stoll 1997, Mili 1991) but is not associated with large for gestational age (Lapunzina 2002). Anal atresia/stenosis risk is elevated with prematurity (Rasmussen 2001). Large intestinal atresia has been associated with intrauterine growth retardation (Khoury 1988). Various investigations found a decrease in risk of these defects with increasing parity and an increase in risk with multiple gestation pregnancy (Mastroiacovo 1999, Riley 1998, Harris 1995, Doyle 1991, Kallen 1986); however, a different investigation reported no such associations (Stoll 1997). Anorectal malformations have been associated when assisted reproductive techniques were used in conception of the fetus (Midrio 2006).

One study identified higher risk of anal atresia/stenosis with consanguinity (Stoll 1997) while another study found no association (Rittler 2001). A small percentage of cases with anal atresia/stenosis have a family history of the same defect (Stoll 1997, Spouge 1986).

FACTORS IN LIFESTYLE OR ENVIRONMENT

Maternal education does not appear to affect risk for anal atresia/stenosis (Stoll 1997). One investigation identified no significant association between maternal nursing occupation and risk of atresia/stenosis of the colon, rectum, or anus (Matte 1993). Paternal occupations of printing or sales do not appear to increase risk of rectal atresia (Irgens 2000). A review article noted increased risk of anal atresia/stenosis with paternal occupation of vehicle manufacturer (Chia 2002).

Maternal diabetes may increase risk for anal atresia/stenosis (Aberg 2001, Bianchi 2000, Stoll 1997, Becerra 1990), although one investigation reported no association between imperforate anus and diabetes (Ramos-Arroyo 1992). There is no apparent association between anal atresia/stenosis and maternal epilepsy, hypertension, fever, flu, hypothyroidism, or hyperthyroidism (Stoll 1997, Khoury 1989).

Anal atresia/stenosis has been reported in infants whose mothers took thalidomide during pregnancy (Bianchi 2000). One study observed no association between maternal use of the antibiotic oxytetracycline during pregnancy and rectal-anal atresia/stenosis (Czeizel 2000 and others found no relationship between cephalosporin antibiotics, nalidixic acid, ampicillin, or the benzodiazepines nitrazepam, medazepam, tofisopam, alprazolum, and clonazepam and recto-anal atresia or stenosis (Eros 2002, Czeizel 2001a, Czeizel 2001b, Czeizel 2001c). However, first trimester maternal exposure to lorazepam does increase the risk for anal atresia; while bromazepam was associated with other digestive system anomalies (Bonnot 2001). There is also an apparent association between anti-asthmatic drugs and anal atresia (Kallen 2007).

While there is limited data on the effects of illicit drugs on fetal development, the use of marijuana does not increase the risk of anal atresia/stenosis (Fried 2002). The use of cocaine also has not been shown to increase the risk of anal atresia/stenosis (Chavez 1989).

Investigations into the association between alcohol and anal atresia/stenosis are mixed (Bianchi 2000; Stoll 1997). Maternal smoking and exposure to X-rays do not appear to cause anal atresia/stenosis (Honein 2001, Stoll 1997, Yuan 1995, Van Den Eeden 1990, Shiono 1986), although one investigation observed increased risk of atresia of rectum, anal canal, and large intestine with maternal smoking (Cornel 1996).

There appears to be higher rates of all non-chromosomal anomalies within groups with low socioeconomic status (Vrijheid 2000). Living in proximity to hazardous waste sites has not been found to affect risk of anal atresia (Dolk 1998). An investigation failed to identify any significant association between anal atresia and proximity to various types of industry (Castilla 2000). Anal atresia does not appear to be related to water chlorination (Kallen and Robert, 2000), maternal exposure to organic solvents (Wennborg 2005), or maternal exposure to indoor pesticides (Berkowitz 2003). One study reported no increased risk of skin-covered anus in regions of Belarus contaminated after the Chernobyl accident (Feshchenko 2002).

No association between maternal folic acid use and anal atresia was found by one study (Czeizel 1996), while another more recent investigation identified reduced risk of imperforate anus with maternal use of folic acid (Myers 2001). Furthermore, a study that examined co-trimoxazole, a combination of trimethoprim and sulfamethoxazole that is a folic acid antagonist, failed to find any association between the medication and anal-rectal atresia/stenosis (Czeizel 1990).

PREVALENCE

Birth prevalence in the United States for anal atresia/stenosis ranges between 1.04 and 7.89 per 10,000 live births ( National Center on Birth Defects and Developmental Disabilities 2006). The rate in Texas among 1999-2003 deliveries was 5.23 cases per 10,000 live births (includes atresia or stenosis of the large intestine) (Texas Department of State Health Services 2006). Differences in prevalence may be due to differences in case inclusion criteria.

REFERENCES

  • Aberg A, Westbom L, Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev 2001;61:85-95.
  • Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics 1990;85:1-9.
  • Berkowitz, G, Obel, J, Deych, Lapinski, R, Godbold, J, Liu, Z, Landrigan, P, Wolff. Exposeure to indoor pesticides during pregnancy in a multiethnic, urban cohort. Environmental Health Perspectives, Vol. 111, No. 1, 2003.
  • Bianchi DW, Crombleholme TM, D’Alton ME. Anorectal atresia (imperforate anus). In: Fetology: Diagnosis and Management of the Fetal Patient. New York: McGraw-Hill, 2000; pp. 499-505.
  • Bianco S, Ettore G. Anorectal malformations and Down’s syndrome. Paediatr Perinat Epidemiol 2000;14:372.
  • Bonnot O, Vollset S, Godet P, D’Amato T, Robert E. Maternal exposure to lorazepam and anal atresia in newborns: results from a hypothesis-generating study of benzodiazepines and malformations. Journal of Clinical Psychopharmacol, Vol. 21, No. 4, 2001.
  • Calzolari E, Cavazzuti GB, Cocchi G, Contrino C, Magnani C, Moretti M, Roncarati E, Salvioli GP, Volpato S. Congenital malformations in 100,000 consecutive births in Emilia Romagna region, northern Italy: comparison with the EUROCAT data. Eur J Epidemiol 1987;3:423-430.
  • Castilla EE, Campana H, Camelo JS. Economic activity and congenital anomalies: an ecologic study in Argentina. Environ Health Perspect 2000;108:193-197.
  • Castilla EE, Lopez-Camelo JS, Campana H. Altitude as a risk factor for congenital anomalies. Am J Med Genet 1999;86:9-14.
  • Castilla EE, Lopez-Camelo JS. The surveillance of birth defects in South America: I. The search for time clusters: epidemics. In: Advances in Mutagenesis Research. Springer-Verlag, New York. 1990 pp. 191-210. Castilla EE, Orioli IM, Lugarinho R, Dutra GP, Lopez-Camelo JS, Campana HE, Spagnolo A, Mastroiacovo P. Monthly and seasonal variations in the frequency of congenital anomalies. Int J Epidemiol 1990;19:399-404.
  • Chavez GF, Cordero JF, Becerra JE. Leading major congenital malformations among minority groups in the United States, 1981-1986. Mor Mortal Wkly Rep CDC Surveill Summ 1988;37:17-24.
  • Chavez GG, Mulinare J, Cordero JF: Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. JAMA 1989; 262:795-8.
  • Chia SE, Shi LM. Review of recent epidemiological studies on paternal occupations and birth defects. Occup Environ Med. 2002;59:149-155.
  • Cornel MC, Erickson JD, Khoury MJ, James LM, Liu Y. Population-based birth-defect and risk factor surveillance: data from the Northern Netherlands. Int J Risk Safety Med 1996;8:197-209.
  • Cuschieri A, EUROCAT Working Group. Descriptive epidemiology of isolated anal anomalies: a survey of 4.6 million births in Europe. Am J Med Genet 2001;103:207-215.
  • Czeizel A, Vitez M. Birth prevalence of five congenital abnormalities of medium frequency in Budapest. Acta Paediatr Acad Sci Hung 1981;22:299-308.
  • Czeizel A. A case-control analysis of the teratogenic effects of co-trimoxazole. Reprod Toxicol 1990;4:305-313.
  • Czeizel AE, Toth M, Rockenbauer M. Population-based case control study of folic acid supplementation during pregnancy. Teratology 1996;53:345-351.
  • Czeizel AE, Rockenbauer M. A population-based case-control teratologic study of oral oxytetracycline treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 2000;88:27-33.
  • Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. Use of cephalosporins during pregnancy and in the presence of congenital abnormalities: a population-based, case-control study. Am J Obstet Gynecol 2001a;184:1289-1296.
  • Czeizel AE, Sorensen HT, Rockenbauer M, Olsen J. A population-based case-control teratologic study of nalidixic acid. Int J Gynaecol Obstet 2001b;73:221-228.
  • Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. A population-based case-control teratologic study of ampicillin treatment during pregnancy. Am J Obstet Gynecol 2001c;185:140-147.
  • Dolk H, Vrijheid M, Armstrong B, Abramsky L, Bianchi F, Garne E, Nelen V, Robert E, Scott JE, Stone D, Tenconi R. Risk of congenital anomalies near hazardous-waste landfill sites in Europe: the EUROHAZCON study. Lancet 1998;352:423-427.
  • Doyle PE, Beral V, Botting B, Wale CJ. Congenital malformations in twins in England and Wales. J Epidemiol Community Health 1991;45:43-48.
  • Eros E, Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. A population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolum and clonazepam treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 2002;101:147-154.
  • Feshchenko SP, Schroder HC, Muller WE, Lazjuk GI. Congenital malformations among newborns and developmental abnormalities among human embryos in Belarus after Chernobyl accident. Cell Mol Biol 2002;48:423-426.
  • Finley WH, Gustavson KH, Hall TM, Hurst DC, Barganier CM, Wiedmeyer JA. Birth defects surveillance: Jefferson County, Alabama, and Uppsala County, Sweden. South Med J 1994;87:440-445.
  • Forrester M, and Merz R. Descriptive epidemiology of anal atresia in Hawaii, 1986-1999. Teratology 66: S12-S16, 2002.
  • Fried P. The consequesnces of marijuana use during pregnancy: a review of the literature. Women and Cannabis: medicine, sciences, and sociology (2002) and Journal of Cannabis Theraputics, Vol. 2, No. ¾, 2002.
  • Harris J, Kallen B, Robert E. Descriptive epidemiology of alimentary tract atresia. Teratology 1995;52:15-29.
  • Garne E, Rasmussen L, Husby S. Gastrointestinal malformations in Funen County, Denmark - epidemiology, associated malformations, surgery and mortality. Eur J Pediatr Surg 2002;12:101-106.
  • Haeusler MC, Berghold A, Stoll C, Barisic I, Clementi M. Prenatal ultrasonographic detection of gastrointestinal obstruction: results from 18 European congenital anomaly registries. Prenat Diagn 2002;22:616-623.
  • Honein MA, Paulozzi LJ, Watkins ML. Maternal smoking and birth defects: validity of birth certificate data for effect estimation. Public Health Rep 2001;116:327-335.
  • Irgens A, Kruger K, Skorve AH, Irgens LM. Birth defects and paternal occupational exposure. Hypotheses tested in a record linkage based dataset. Acta Obstet Gynecol Scand 2000;79:465-470.
  • Kallen B, Mastroiacovo P, Robert E. Major congenital malformations in Down syndrome. Am J Med Genet 1996;65:160-166.
  • Kallen B, Olausson PO. Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the infants. Eur. J. Clin. Pharmacol. 2007 Apr;63(4):383-8. Epub 2007 Feb 6.
  • Kallen BA, Robert E. Drinking water chlorination and delivery outcome-a registry-based study in Sweden. Reprod Toxicol 2000;14:303-309.
  • Khoury MJ, Becerra JE, d'Almada PJ. Maternal thyroid disease and risk of birth defects in offspring: a population-based case-control study. Paediatr Perinat Epidemiol 1989;3:402-420.
  • Khoury MJ, Erickson JD, Cordero JF, McCarthy BJ. Congenital malformations and intrauterine growth retardation: a population study. Pediatrics 1988;82:83-90.
  • Lapunzina P, Lopez Camelo JS, Rittler M, Castilla EE. Risks of congenital anomalies in large for gestational age infants. J Pediatr 2002;140:200-204.
  • Lary JM, Paulozzi LJ. Sex differences in the prevalence of human birth defects: a population-based study. Teratology 2001;64:237-251.
  • Leck I, Lancashire RJ. Birth prevalence of malformations in members of different ethnic groups and in the offspring of matings between them, in Birmingham, England. J Epidemiol Community Health 1995;49:171-179.
  • Lisi A, Botto LD, Rittler M, Castilla E, Bianca S, Bianchi F, Botting B, De Walle H, Erickson JD, Gatt M, De Vigan C, Irgens L, Johnson W, Lancaster P, Merlob P, Mutchinick OM, Ritvanen A, Robert E, Scarano G, Stoll C, Mastroiacovo P. Sex and congenital malformations: an international perspective. Am J Med Genet A. 2005 Apr 1;134(1):49-57. Erratum in: Am J Med Geet A. 2005 May 1;134(4):463.
  • Martinez-Frias M, Permejo E, Rodriguez-Pinella E. Anal atresia, vertebral, genital, and urinary tract anomalies: a primary polytopic developmental field defect identified through an epidemiological analysis of associations. American Journal of Medical Genetics, 95: 169-173, 2000.
  • Mastroiacovo P, Castilla EE, Arpino C, Botting B, Cocchi G, Goujard J, Marinacci C, Merlob P, Metneki J, Mutchinick O, Ritvanen A, Rosano A. Congenital malformations in twins: an international study. Am J Med Genet 1999;83:117-124.
  • Matte TD, Mulinare J, Erickson JD. Case-control study of congenital defects and parental employment in health care. Am J Ind Med 1993;24:11-23.
  • McIntosh GC, Olshan AF, Baird PA. Paternal age and the risk of birth defects in offspring. Epidemiology 1995;6:282-288.
  • Midrio P, Nogare CD, Di Gianantonio E, Clementi M. Are congenital anorectal malformations more frequent in newborns conceived with assisted reproductive techniques? Reprod. Toxicol. 2006 Nov;22(4):576-7. Epub 2006 May 16.
  • Mili F, Edmonds LD, Khoury MJ, McClearn AB. Prevalence of birth defects among low-birth-weight infants. A population study. Am J Dis Child 1991;145:1313-1318.
  • Moore, K, Persaud, T. The developing human: clinically orientated embryology, 1998.
  • Myers MF, Li S, Correa-Villasenor A. Li Z, Moore CA, Hong SX, Berry RJ. Folic acid supplementation and risk for imperforate anus in China. Am J Epidemiol 2001;154:1051-1056.
  • National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention. Birth defects surveillance data from selected states, 1999-2003. Birth Defects Res. Part A Clin. Mol. Teratol. 2006 Dec;76(12):894-960.
  • Ramos-Arroyo MA, Rodriguez-Pinilla E, Cordero JF. Maternal diabetes: the risk for specific birth defects. Eur J Epidemiol 1992;8:503-508.
  • Rasmussen SA, Moore CA, Paulozzi LJ, Rhodenhiser EP. Risk for birth defects among premature infants: A population-based study. J Pediatr 2001;138:668-673.
  • Riley MM, Halliday JL, Lumley JM. Congenital malformations in Victoria, Australia, 1983-95: an overview of infant characteristics. J Paediatr Child Health 1998;34:233-240.
  • Rittler M, Liascovich R, Lopez-Camelo J, Castilla EE. Parental consanguinity in specific types of congenital anomalies. Am J Med Genet 2001;102:36-43.
  • Sekhobo JP, Druschel CM. An evaluation of congenital malformations surveillance in New York State: an application of Centers for Disease Control and Prevention (CDC) guidelines for evaluating surveillance systems. Public Health Rep 2001;116:296-305.
  • Shiono PH, Klebanoff MA, Berendes HW. Congenital malformations and maternal smoking during pregnancy. Teratology 1986;34:65-71.
  • Spouge D, Baird PA. Imperforate anus in 700,000 consecutive liveborn infants. Am J Med Genet Suppl 1986;2:151-161.
  • Stoll C, Alembik Y, Roth MP, Dott B. Risk factors in congenital anal atresias. Ann Genet 1997;40:197-204.
  • Stoll C, Alembik Y, Dott B, Roth MP. Evaluation of prenatal diagnosis of congenital gastro-intestinal atresias. Eur J Epidemiol 1996;12:611-616.
  • Stoll C, EUROCAT Working Group. Distribution of single organ malformations in European populations. Ann Genet 1995;38:32-43.
  • Texas Department of State Health Services. Texas Birth Defects registry report of birth defects among 1999-2003 deliveries. 2006.
  • Torfs CP, Christianson RE. Anomalies in Down syndrome individuals in a large population-based registry. Am J Med Genet 1998;77:431-438.
  • Van Den Eeden SK, Karagas MR, Daling JR, Vaughan TL. A case-control study of maternal smoking and congenital malformations. Paediatr Perinat Epidemiol 1990;4:147-155.
  • Vrijheid M, Dolk H, Stone D, Abramsky L, Alberman E, Scott J. Socioeconomic inequalities in the risk of congenial anomaly. Arch Dis Child. 2000; 82, 349-352.
  • Wennborg H, Magnusson L, Bonde J, Olsen J. Congenital malformations related to maternal exposure to specific agents in biomedial research laboratories. JOEM 2005:47(1).
  • Yang P, Khoury MJ, Stewart WF, Beaty TH, Chee E, Beatty JC, Diamond EL, Gordis L. Comparative epidemiology of selected midline congenital abnormalities. Genet Epidemiol 1994;11:141-154.
  • Yuan P, Okazaki I, Kuroki Y. Anal atresia: effect of smoking and drinking habits during pregnancy. Jpn J Hum Genet 1995;40:327-332.
  • Zhu M, Druschel C, Lin S. Maternal birthplace and major congenital malformations among New York Hispanics. Birth Defects Res. Part A Clin. Mol. Teratol. 2006 Jun;76(6):467-73.

Please Note: The primary purpose of this report is to provide background necessary for conducting cluster investigations. It summarizes literature about risk factors associated with this defect. The strengths and limitations of each reference were not critically examined prior to inclusion in this report. Consumers and professionals using this information are advised to consult the references given for more in-depth information. This report is for information purposes only and is not intended to diagnose, cure, mitigate, treat, or prevent disease or other conditions and is not intended to provide a determination or assessment of the state of health. Individuals affected by this condition should consult their physician and when appropriate, seek genetic counseling.

 

For more information:

Birth Defects Epidemiology and Surveillance
Texas Department of State Health Services
1100 W. 49th Street, Austin, Texas 78756
512-776-7232 Fax 512-776-7330

Return to Birth Defects Risk Factor Page

Document E58-10957                    Revised June 2007

Birth Defects Epidemiology and Surveillance Home Page

Last updated February 10, 2012